DoseRoutine supplement library logoDoseRoutine
Cream probiotic capsules in a glass dish on pale grey
DoseRoutine Akkermansia muciniphila — Cream probiotic capsules in a glass dish on pale grey. Original DoseRoutine photography.
supplementNot FDA-approvedSold as a probiotic dietary supplement

Akkermansia muciniphilaBenefits, Dosage & Interactions

Also known as: akkermansia, A. muciniphila, pasteurized akkermansia

Akkermansia muciniphila is a mucin-degrading bacterium of the intestinal mucus layer. Lower relative abundance has been observed alongside obesity and metabolic dysfunction in observational work, which drove interest in it as a probiotic. It is typically taken in the morning.

How much Akkermansia muciniphila do people take?

The 2019 pilot trial used 10^10 bacteria daily, live or pasteurized; the pasteurized form carried the measured metabolic signals. Route reported: Oral capsule. Frequency reported: Once daily in the published protocol. These are amounts documented in the cited studies and labels for Akkermansia muciniphila — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

See the full reported protocol and its sources

Last reviewed: · Sourcing & review process

Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.

Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence

One published human randomized trial; results not yet replicated.

Plasma half-life
Not applicable — a live or pasteurized bacterial strain
Typical timing
in the morning
Default unit
mg

What published protocols report

Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.

Reported amounts
The 2019 pilot trial used 10^10 bacteria daily, live or pasteurized; the pasteurized form carried the measured metabolic signals[1][2]
Route studied
Oral capsule[1][2]
Frequency
Once daily in the published protocol[1][2]
Cycle length
3 months in the pilot trial[1][2]
Half-life
Not applicable — a live or pasteurized bacterial strain[1][2]
Storage
Per label; many products require refrigeration[1][2]

Reported for Akkermansia muciniphila in the cited sources. Published ranges are not dosing advice.

References & evidence

Documents the Akkermansia muciniphila entry is written from. Each number matches an inline marker above.

  1. [1]Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory studyDepommier C, et al. · Nature Medicine · 2019 · Peer-reviewed · PMID 31263284
  2. [2]Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphilaCani PD, de Vos WM · Frontiers in Microbiology · 2017 · Peer-reviewed · PMID 28955325

What is Akkermansia muciniphila?

Akkermansia muciniphila is a mucin-degrading bacterium of the intestinal mucus layer. Lower relative abundance has been observed alongside obesity and metabolic dysfunction in observational work, which drove interest in it as a probiotic. The landmark human data is a small pilot trial of pasteurised A. muciniphila in overweight adults with insulin resistance; larger confirmatory trials are still limited.

Put it into practice

Reading about Akkermansia muciniphila is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.

What interacts with Akkermansia muciniphila?

Documented interactions for Akkermansia muciniphila: the other compound, the severity and confidence of the interaction, what happens, and what to do.
Interacts withSeverityTypeWhat happensWhat to do
Any glp1 + supplementNoteCategory ruleConfidence: theoreticalGLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.Source pendingTime oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider.
Any supplement + medicationNoteCategory ruleConfidence: theoreticalSome supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pendingSpecific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.

Frequently asked questions about Akkermansia muciniphila

Akkermansia muciniphila lives in and feeds on the intestinal mucus layer, and in animal work it is associated with a thicker mucus barrier and improved metabolic markers. Whether supplementing it reproduces that in humans is still an open question.

A small three-month pilot in overweight, insulin-resistant adults reported improved insulin sensitivity and some markers of liver and metabolic health with pasteurised A. muciniphila. It was a pilot, and the broader evidence base is thin.

Most human work used pasteurised cells, which in that trial performed at least as well as live bacteria and are far easier to stabilise in a capsule.

In the published trial it was well tolerated with no significant safety signals. People who are immunocompromised, have a central venous catheter or have serious gut disease should not start a probiotic without medical advice.

Diet influences abundance: polyphenol-rich foods, fibre and metabolic improvements have all been associated with higher levels. Food changes are the lower-risk starting point.

Akkermansia muciniphila is a supplement, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Akkermansia muciniphila is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Akkermansia muciniphila with no sign-up.

Akkermansia muciniphila is typically taken in the morning. Ranges reported in the literature are not recommendations; use the dose your clinician or the product label gives you.

Combining a supplement like Akkermansia muciniphila with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions

Each peptide class carries its own profile against Akkermansia muciniphila: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.

Published frequency for Akkermansia muciniphila varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps

The effect of a missed dose of Akkermansia muciniphila depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.

For Akkermansia muciniphila the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.

The 2019 pilot trial used 10^10 bacteria daily, live or pasteurized; the pasteurized form carried the measured metabolic signals. Route reported: Oral capsule. Frequency reported: Once daily in the published protocol. These are amounts documented in the cited studies and labels for Akkermansia muciniphila — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

Verify at

Publisher search links for Akkermansia muciniphila. These are places to check the information — they are not citations, so they are not numbered.

DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.

What is the short answer on Akkermansia muciniphila?

Plain-text summary, safe to quote verbatim:

Akkermansia muciniphila is a mucin-degrading bacterium of the intestinal mucus layer. Lower relative abundance has been observed alongside obesity and metabolic dysfunction in observational work, which drove interest in it as a probiotic. It is typically taken in the morning.
Source: DoseRoutine — https://doseroutine.com/library/akkermansia-muciniphila

Akkermansia muciniphila cheat sheet

DoseRoutine cheat sheet · Supplement

Akkermansia muciniphila

Akkermansia muciniphila is a mucin-degrading bacterium of the intestinal mucus layer. Lower relative abundance has been observed alongside obesity and metabolic dysfunction in observational work, which drove interest in it as a probiotic.

Evidence

Moderate

One published human randomized trial; results not yet replicated.

Studied range

The 2019 pilot trial used 10^10 bacteria daily, live or pasteurized; the pasteurized form carried the measured metabolic signals

Route

Oral capsule

Frequency studied

Once daily in the published protocol

Half-life

Not applicable — a live or pasteurized bacterial strain

Timing

in the morning

Storage

Per label; many products require refrigeration

Not FDA-approvedSold as a probiotic dietary supplementGut HealthMetabolic

Key references

  1. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study (2019)
  2. Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila (2017)

Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/akkermansia-muciniphila

Cite this page

Using this in an article, AI answer, or research note? Please attribute:

DoseRoutine. (2026). Akkermansia muciniphila — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/akkermansia-muciniphila
Canonical URL

What compounds are similar to Akkermansia muciniphila?

Others in the supplement category or studied for the same goals.

Track Akkermansia muciniphila in DoseRoutine

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →

Latest research from DoseRoutine

Browse all DoseRoutine research updates

Track Akkermansia Muciniphila in your own routine

Add Akkermansia Muciniphila to your stack, get reminders at the right times, and see interaction notes with everything else you take. Free to start — no card needed.

Track Akkermansia Muciniphila freeSign in